Clinical Lymphoma Myeloma & Leukemia

P-100: Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma.

Clinical Lymphoma Myeloma & Leukemia

Ian Ferguson, Tony Lin, Christine Lam, Hao Shao, Kevin Tharp, Brian Van Ness, Jason Gestwicki, Arun Wiita

P-103: Profiling the myeloma cell surface proteome reveals CCR10 as a potential immunotherapeutic target.

Clinical Lymphoma Myeloma & Leukemia

Bonell Patino-Escobar, Corynn Kasap, Ian Ferguson, Martina Hale, Arun Wiita

MM-378: Inhibitory and Stimulatory Interplay Between Myeloma Tumor and T Cells.

Clinical Lymphoma Myeloma & Leukemia

August Dietrich, Cassandra Burnett, Thomas Martin, Arun Wiita, Kole Roybal, Justin Eyquem

Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis.

Clinical Lymphoma Myeloma & Leukemia

Vishesh Sarin, Katharine Yu, Marina Sirota, Arun Wiita

DNA methyltransferase inhibitors upregulate CD38 expression and enhance daratumumab efficacy in multiple myeloma.

Clinical Lymphoma Myeloma & Leukemia

Priya Choudhry, Margarette Mariano, Huimin Geng, Arun Wiita

Hijacking Myeloma Metabolism to Target Cytotoxic Chemotherapy to Malignant Plasma Cells With Decreased Bone Marrow Toxicity.

Clinical Lymphoma Myeloma & Leukemia

Arun Wiita, Hui Liu, Christine Lam, Bernd Jandeleit, Wolf-Nicolas Fischer, Kerry Koller, Byron Hann